Suppr超能文献

α4β1纤连蛋白配体CS-1、肝素II和RGD在B淋巴细胞中诱导不同的细胞内事件。与内皮配体血管细胞黏附分子-1(VCAM-1)的作用比较。

The alpha 4 beta 1 fibronectin ligands CS-1, Hep II, and RGD induce different intracellular events in B lymphoid cells. Comparison with the effects of the endothelial ligand VCAM-1.

作者信息

Domínguez-Jiménez C, Sánchez-Aparicio P, Albar J P, García-Pardo A

机构信息

Departmento de Inmunología, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.

出版信息

Cell Adhes Commun. 1996 Nov;4(4-5):251-67. doi: 10.3109/15419069609010770.

Abstract

The lymphocyte integrin alpha 4 beta 1 is the receptor for the Hep II domain and CS-1 site in fibronectin (Fn) as well as for VCAM-1. We recently showed that upon activation with anti-beta 1 mAb TS2/16, alpha 4 beta 1 also recognizes the RGD Fn sequence. To determine the physiological role of these multiple interactions, we have now studied some intracellular events induced by "resting" and activated alpha 4 beta 1 binding to its different ligands. Analyses of actin and tubulin reorganization upon adhesion of B lymphoid cells to Fn fragments or VCAM-1 showed that VCAM-1, a 38 kDa fragment (Hep II+CS-1), and the CS-1 synthetic peptide induced formation of transient cytoplasmic projections; however, cells attached to a 58 kDa (Hep II) or 80 kDa (RGD) fragments remained rounded. Using transfilter assays, we showed that VCAM-1, 38 kDa and CS-1 also induced dose-dependent B cell migration mediated by alpha 4 beta 1. Furthermore, these three ligands, but not the 80 kDa fragment or a synthetic peptide (H1) containing a sequence from Hep II shown to bind alpha 4 beta 1, induced tyrosine phosphorylation of a 110 kDa protein. Activation of alpha 4 beta 1 with TS2/16 inhibited the cytoplasmic protrusions and cell migration but did not affect the pattern of phosphorylation. Our results indicate that the various alpha 4 beta 1 ligands induce different cellular responses. Most importantly they show that alpha 4 beta 1 interaction with CS-1 is sufficient to trigger intracellular events in B cells. Furthermore, they suggest a regulation by the activation form of the receptor as well as by the ligand in events involving lymphocyte adhesion and migration.

摘要

淋巴细胞整合素α4β1是纤连蛋白(Fn)中Hep II结构域和CS-1位点以及血管细胞黏附分子-1(VCAM-1)的受体。我们最近发现,用抗β1单克隆抗体TS2/16激活后,α4β1也能识别RGD Fn序列。为了确定这些多重相互作用的生理作用,我们现在研究了“静止”和激活的α4β1与其不同配体结合所诱导的一些细胞内事件。对B淋巴细胞黏附于Fn片段或VCAM-1时肌动蛋白和微管蛋白重组的分析表明,VCAM-1、一个38 kDa的片段(Hep II+CS-1)和CS-1合成肽可诱导形成短暂的细胞质突起;然而,黏附于58 kDa(Hep II)或80 kDa(RGD)片段的细胞仍保持圆形。通过跨膜分析,我们发现VCAM-1、38 kDa和CS-1也能诱导由α4β1介导的剂量依赖性B细胞迁移。此外,这三种配体,而不是80 kDa片段或含有已证明能结合α4β1的Hep II序列的合成肽(H1),可诱导一种110 kDa蛋白质的酪氨酸磷酸化。用TS2/16激活α4β1可抑制细胞质突起和细胞迁移,但不影响磷酸化模式。我们的结果表明,各种α4β1配体可诱导不同的细胞反应。最重要的是,它们表明α4β1与CS-1的相互作用足以触发B细胞中的细胞内事件。此外,它们还提示在涉及淋巴细胞黏附和迁移的事件中,受体的激活形式以及配体均有调节作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验